CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is 4.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $310,500 | -36.5% | 135,000 | +0.7% | 0.02% | -42.9% |
| Q2 2023 | $489,231 | -46.1% | 134,036 | -47.2% | 0.04% | -50.6% |
| Q1 2023 | $906,909 | -12.8% | 254,036 | -30.4% | 0.08% | +7.6% |
| Q4 2022 | $1,040,250 | -12.8% | 365,000 | -31.8% | 0.08% | -12.2% |
| Q3 2022 | $1,193,000 | -17.4% | 535,000 | -7.8% | 0.09% | -9.1% |
| Q2 2022 | $1,444,000 | -26.9% | 580,000 | +43.2% | 0.10% | -26.7% |
| Q1 2022 | $1,976,000 | -8.1% | 405,000 | +113.2% | 0.14% | +8.9% |
| Q4 2021 | $2,149,000 | +43.5% | 190,000 | +84.8% | 0.12% | +57.0% |
| Q3 2021 | $1,498,000 | -14.7% | 102,816 | -31.8% | 0.08% | -7.1% |
| Q2 2021 | $1,756,000 | -6.9% | 150,700 | -2.5% | 0.08% | +21.4% |
| Q1 2021 | $1,886,000 | +77.4% | 154,600 | +81.9% | 0.07% | +84.2% |
| Q4 2020 | $1,063,000 | – | 85,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |